Form D — Liminatus Pharma, Inc.
0001104659-26-075732 · filed 2026-06-18
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $1,861,920
- Total sold
- $1,861,920
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Liminatus Pharma, Inc.
- CIK
- 1971387
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2251 STERN GOODMAN STREET, SUITE E
FULLERTON, CA 92833 - Phone
- 213-273-5453
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Chris Kim · Executive OfficerFullerton, CA Find on LinkedIn ↗
-
Scott Dam · Executive OfficerFullerton, CA Find on LinkedIn ↗
-
Byong C. Yoo · Executive OfficerFullerton, CA Find on LinkedIn ↗
-
Sang-jin Daniel Lee · Executive OfficerFullerton, CA Find on LinkedIn ↗
-
Beom K. Choi · Executive OfficerFullerton, CA Find on LinkedIn ↗
-
Eun Sook Lee · DirectorFullerton, CA Find on LinkedIn ↗
-
Nicholas Fernandez · DirectorFullerton, CA Find on LinkedIn ↗
-
Ji Yeon Baek · DirectorFullerton, CA Find on LinkedIn ↗
View original on SEC EDGAR.